-
The PROMETRIKA team attended the Fierce Biotech Week conference, which offered a front row seat to the evolving landscape of clinical research, where innovation is not just a buzzword but a driving force. The conversations centered around the growing adoption of Risk-Based Quality Management (RBQM) and the ongoing evolution of the Trial Master File (TMF) as a critical tool for inspection readiness. These topics not only dominated sessions and panels, they sparked dynamic roundtable discussions, signaling a shift in how the industry is approaching trial efficiency, compliance and data integrity.
-
Leveraging the advantages of electronically captured patient-reported data in early phase trials
As clinical trial planning begins, PROMETRIKA Clinical Trial Managers (CTMs) and Project Managers (PMs) are often asked by Sponsors to assess the pros and cons of using paper documentation (e.g., diaries) vs. electronic data entry for patient-reported data. Our broad experience with different phases of clinical trials helps us advise Sponsors on this decision.
THOUGHT LEADERSHIP
